#RENALAF - Twitter Hashtag

11 months ago

Aymeric Couturier Shares Recent Studies on Anticoagulation and Atrial Fibrillation in Dialysis https://t.co/fWnCj9RtGJ #AF #Anticoagulation #Apixaban #AtrialFibrillation #AXADIAAFNET8 #DANWARD #DOACs #Edoxaban #Health #Hematology #HemostasisToday #JASN #Medicine #RENALAF #Rivaroxaban #SACKSAFEDPilotTrial #VALKYRIE #VISIONAIRE #VKAs #Warfarin #MedEd #MedX

0

3

0

1

59

Duke Clinical Research Institute @DCRINews

almost 6 years ago

Curious about pharmacokinetic data from #RENALAF? Check out this #ESCCongress eposter from DCRI's @sean_pokorney. See more DCRI work at #ESC2020: https://t.co/Z3SHnAVXL4 @escardio #CardioTwitter

DCRINews's tweet photo. Curious about pharmacokinetic data from #RENALAF? Check out this #ESCCongress eposter from DCRI's @sean_pokorney. See more DCRI work at #ESC2020: https://t.co/Z3SHnAVXL4 @escardio #CardioTwitter https://t.co/kff93bV2Af

0

5

2

0

Sean Pokorney @sean_pokorney

over 6 years ago

Power limited by sample size. Bleeding safety was primary endpoint. CV death secondary endpoint so would not focus on that. Only 1 ICH in each arm. Major/clinically relevant non-major bleeding rates similar in both arms. Apixaban seems reasonable. PK/PD data coming. #RENALAF

Edip Gurol

@guroledip

over 6 years ago

Despite the fact that apixaban competed against a warfarin arm with Time in therapeutic range (TTR) of 44.3%... I want to learn more about “the trial was stopped because of loss of funding”. @DrJasonAndrade @JonPicciniSr @JonHsuMD

2

18

4

1

0

2

6

2

0

Manish M Sood MD @Msood99M

over 6 years ago

#renalAF just presented @AHA19. Warfarin vs apixaban in HD. And the answer is ....,...no answer! Just more questions. Unable to enroll.

0

8

2

1

0

Yury Mareev @YMareev

over 6 years ago

More #renalAF data. The aim was to compare safety of apixaban vs warfarin in hemodialysis AF. The bleeding rate was similar. There was no enough data to compare efficacy. #AHA2019 #cardiotwitter

YMareev's tweet photo. More #renalAF data. The aim was to compare safety of apixaban vs warfarin in hemodialysis AF. The bleeding rate was similar. There was no enough data to compare efficacy.
#AHA2019 #cardiotwitter https://t.co/UXpKCtn2Qt

0

10

5

1

0

Yury Mareev @YMareev

over 6 years ago

#renalAF is the first RCT on NOAC (Apixaban) vs Warfarin in hemodialysis patients with AF. There was no difference in the outcome but it stops early due to slow enrollment and it's power is limited. #cardiotwitter #AHA2019